The enhanced effects of liposome microbubble under ultrasound mediated gene transfection conditions
10.3760/cma.j.issn.1004-4477.2009.01.022
- VernacularTitle:脂质体微泡对超声介导基因转染的增效作用研究
- Author:
Zhiyi CHEN
;
Mingxing XIE
;
Xinfang WANG
;
Qing Lü
;
Shangwei DING
- Publication Type:Journal Article
- Keywords:
Ultrasonography;
Microbubbles;
Liposomes;
Transfection;
Gene therapy
- From:Chinese Journal of Ultrasonography
2009;18(1):62-66
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the transfeetion efficiency and safety of liposome microbubble(LM)on red fluorescent protein(RFP)in vitro and in vivo under ultrasound mediated gene transfection(USMGT)conditions.Methods Plasmids containing RFP were added to cultured Hela cells followed by ultrasound (US)exposure with LM.Different concentration of LM,US intensity and exposure time were optimized.Transfection efficiency was evaluated by fluorescent microscopy and FACS.Cell viability was verified by propidium iodide assay.In transplanted tumors in vivo study,LM and plasmid(P)were injected into the nude mice followed by US exposure(P+LM+US group).Nude mice undergoing plasmid injection alone(P group),plasmid injection and US exposure(P+US group)and plasmid and LM injection(P+LM group)were used as controls.Frozen section and histological examination were conducted and RFP expression was evaluated.Results LM and US exposure significantly increased transfeetion efficiency in cultured Hela cells (P＜ 0.01).Transfection efficiency was the most prominent under the condition of US intensity of 1.0 W/cm2 with 6%LM,duration 3 min.No apparent cell damage was found in the all groups.In transplanted tumors,strong RFP was seen in P+LM+US group.It was significantly higher than in any other groups(P＜0.0 1).No tissue damage was seen histologically.Conclusions LM could enhance USMGT effectively without causing any apparently adverse effect in vitro and in vivo.This method would be a novel,effective,safe non-viral gene transfection method and provide an alternative to current clinical gene therapy.
